 |
|
|
|
|
Conference Call on the intended acquisition of CeNeS Pharmaceuticals
plc by PAION AG |
|
Corporate news announcement processed and transmitted by Hugin ASA.
The issuer is solely responsible for the content of this
announcement.
----------------------------------------------------------------------
--------------
PAION AG (Frankfurt Stock Exchange, Prime Standard: PA8) intends to
acquire Cambridge (UK) based CeNeS Pharmaceuticals plc (London AIM,
CEN.L).
Today at 11:30 a.m. CEST (10:30 a.m. BST)
PAION and CeNeS will host a conference call on the proposed
transaction.
The conference call will be conducted in English.
Participants may dial
+49 (0)69 5007 1314 (from Germany)
+44 (0)20 7806 1964 (from UK)
Passcode 7460792
To allow for smooth processing we suggest that you dial in 10 minutes
before the beginning of the call.
In addition, a webcast presentation will be accessible during the
call through
http://www.thomson-webcast.net/de/dispatching/?paion_080410misc.
The dial-in details and the webcast link are also available on the
companies' websites www.paion.de and www.cenes.com.
--- End of Message ---
CeNeS Pharmaceuticals Plc
Compass House, Vision Park, Chivers Way,
Histon Cambridge UK
WKN: 913665; ISIN: GB0002070505;
Listed: Freiverkehr in Börse
Berlin, Freiverkehr in Frankfurter Wertpapierbörse;
|
|
|
|
| |
|
durchschnittliche Punktzahl: 0
Stimmen: 0
| |
|
|
|
| |
